eXoZymes, Inc. (EXOZ)
6.25
-0.18
(-2.87%)
USD |
NASDAQ |
Sep 21, 16:00
6.25
0.00 (0.00%)
After-Hours: 20:00
eXoZymes Market Cap : 58.01M for Sept. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 59.73M |
| September 17, 2026 | 57.45M |
| September 16, 2026 | 57.17M |
| September 15, 2026 | 61.03M |
| September 14, 2026 | 58.29M |
| September 11, 2026 | 58.49M |
| September 10, 2026 | 57.27M |
| September 09, 2026 | 57.27M |
| September 08, 2026 | 58.57M |
| September 04, 2026 | 63.58M |
| September 03, 2026 | 63.11M |
| September 02, 2026 | 63.02M |
| September 01, 2026 | 60.33M |
| August 31, 2026 | 62.46M |
| August 28, 2026 | 66.53M |
| August 27, 2026 | 66.59M |
| August 26, 2026 | 69.84M |
| August 25, 2026 | 69.89M |
| August 24, 2026 | 64.51M |
| August 21, 2026 | 66.36M |
| August 20, 2026 | 65.34M |
| August 19, 2026 | 59.40M |
| August 18, 2026 | 59.31M |
| August 17, 2026 | 55.97M |
| August 14, 2026 | 54.02M |
| Date | Value |
|---|---|
| August 13, 2026 | 55.69M |
| August 12, 2026 | 53.46M |
| August 11, 2026 | 53.46M |
| August 10, 2026 | 44.09M |
| August 07, 2026 | 43.29M |
| August 06, 2026 | 43.80M |
| August 05, 2026 | 46.13M |
| August 04, 2026 | 39.17M |
| August 03, 2026 | 39.00M |
| July 31, 2026 | 39.43M |
| July 30, 2026 | 39.00M |
| July 29, 2026 | 37.31M |
| July 28, 2026 | 37.31M |
| July 27, 2026 | 38.58M |
| July 24, 2026 | 39.94M |
| July 23, 2026 | 39.85M |
| July 22, 2026 | 43.50M |
| July 21, 2026 | 45.15M |
| July 20, 2026 | 47.48M |
| July 17, 2026 | 51.04M |
| July 16, 2026 | 52.74M |
| July 15, 2026 | 51.89M |
| July 14, 2026 | 59.35M |
| July 13, 2026 | 54.01M |
| July 10, 2026 | 59.10M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Anika Therapeutics, Inc. | 277.30M |
| Perspective Therapeutics, Inc. | 338.27M |
| MiMedx Group, Inc. | 700.93M |
| ABVC BioPharma, Inc. | 30.15M |
| bioAffinity Technologies, Inc. | 3.482M |
Market Cap Related Metrics
| PEG Ratio | -0.2403 |
| Price to Book Value | 15.88 |
| Price | 6.25 |
| Earnings Yield | -19.23% |
| PEGY Ratio | -0.2403 |